Jim Wilson‘s pioneering gene therapy explorations have helped launch eight companies focused on translating his 40 years of ...

JCR Pharmaceuticals has achieved proof of concept for its gene therapy technology—just in time to lose partner Takeda as the pharma pivots away from adeno-associated viruses. The Japanese ...

Gene therapy, a technique that is revolutionizing ... we have generated a detailed map of viral delivery to tissues in mice, the most commonly used experimental animal for preclinical studies." ...

Combining gene therapy with light therapy, researchers say they have found a potential new approach to treating prostate cancer, publishing their proof-of-concept findings in Molecular Therapy ...

To bring gene therapy to the clinic, scientists now use adeno-associated viruses (AAVs) for safe and effective gene delivery.

A major concern for those intending to bring cell and gene therapy products to market is the manufacturing needs as the product moves from small- to large-scale. In order to keep up with these changes ...

The concept of gene therapy arose during the 1960s and 1970s and is still in its infancy, meaning there is a paucity of reliable, long-term data on the safety and efficacy of this therapy.

You can reach Katie on Signal at palmer.01. NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship ...

and gene therapy. “The concept for this therapy started from a conversation I had with Mark Walters around 10 years ago, so it’s gratifying to see it advance to a clinical trial,” said Doudna, PhD, ...